Related Experiment Video
Updated: Apr 28, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Duration and magnitude of vasopressor support predicts poor outcome after infant cardiac operations
Sheri S Crow1, Jeffrey A Robinson1, Harold M Burkhart2
1Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.
Insights
A new score, the VISindex, improves prediction of poor outcomes in infants after heart surgery by considering vasopressor duration and magnitude. This enhanced vasoactive inotrope score (VIS) offers better sensitivity for identifying infants at risk for prolonged ventilation or ICU stays.
Area of Science:
- Pediatric Cardiac Surgery
- Critical Care Medicine
- Pharmacology
Background:
- The vasoactive inotrope score (VIS) quantifies vasopressor dose at a single time point.
- Current VIS lacks sensitivity in predicting adverse outcomes post-cardiac surgery.
- Improved prediction models are needed for postcardiac surgical infants.
Purpose of the Study:
- To develop and validate a novel score (VISindex) that incorporates vasopressor duration and magnitude.
- To compare the predictive performance of VISindex against the traditional maximum VIS (maxVIS).
- To enhance the sensitivity of VIS for predicting poor outcomes in infants undergoing cardiac operations.
Main Methods:
- Retrospective review of 244 infants (≤365 days) undergoing cardiopulmonary bypass for congenital cardiac operations (2002-2011).
- Hourly VIS calculation for the first 72 postoperative hours.
- Defined poor outcome as prolonged mechanical ventilation (≥6 days) or ICU length of stay (≥12 days).
- Developed VISindex by integrating time-dependent vasopressor data and compared its predictive accuracy (AUC) with maxVIS.
Main Results:
- The VISindex showed superior sensitivity in predicting prolonged mechanical ventilation (AUC, 0.85) compared to maxVIS (AUC, 0.80).
- VISindex also demonstrated improved prediction for intensive care unit length of stay (AUC, 0.84) versus maxVIS (AUC, 0.77).
- These findings were significant within the study population of infants undergoing cardiac surgery.
Conclusions:
- The VISindex effectively incorporates both magnitude and duration of vasopressor support.
- This enhanced score significantly improves the prediction of poor outcomes in infants post-cardiac surgery.
- VISindex offers a more sensitive tool for risk stratification in pediatric cardiac critical care.
Background:
The vasoactive inotrope score (VIS) is a sum of the total vasopressor dose at a single point in time. Incorporating duration and magnitude of vasopressor requirements during the postcardiac surgical period could improve VIS sensitivity for predicting poor outcome.
Methods:
This is a retrospective review of 244 infants (aged ≤365 days) who underwent cardiopulmonary bypass during congenital cardiac operations from 2002 to 2011. The VIS was calculated hourly for the first 72 hours. Poor outcome was defined as prolonged mechanical ventilation (≥6 days) or intensive care length of stay (≥12 days). First, the association between the maximum VIS (maxVIS) in the first 48 postoperative hours and poor outcome was confirmed for our study population. Next, postoperative intervals and VIS values that were significantly associated with poor outcome were identified and incorporated into a formula, termed the VISindex, which was compared with the traditional maxVIS.
Results:
The VISindex demonstrated improved sensitivity for predicting prolonged mechanical ventilation (VISindex: area under the curve [AUC], 0.85; 95% confidence interval [CI], 0.79 to 0.90; maxVIS: AUC, 0.80; 95% CI, 0.75 to 0.86) and intensive care unit length of stay (VISindex: AUC, 0.84; 95% CI, 0.79 to 0.89; maxVIS: AUC, 0.77; 95% CI, 0.71 to 0.83) after cardiac operations in infants.
Conclusions:
Incorporating magnitude and duration of postoperative vasopressor support into the VIS improves its sensitivity for predicting poor outcome.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Aneurysm IV: Nursing Management
Heart Failure V: Medical Management

